Sun Pharma to present long-term cancer drug data at ESMO 2026

UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell carcinoma
This is a short summary. The full story is published by Indianpharmapost.
Read full story at Indianpharmapost
